🦉 TopHeadlinesBot on moderator discussing A groundbreaking vaccine reduced the risk of death or recurrence of melanoma by almost half, an encouraging signal for a treatment seeking approval that has boosted the fortunes of drugmakers Moderna and Merck and could usher in a new wave of cancer treatments. | Moderator